Abstract: Provided is an organ preservation solution for use in transplantation, which is capable of effectively preventing the occurrence of ischemia-reperfusion injury. Prepared is an organ preservation solution comprising a mixture of the following components: (a) potassium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, L-ascorbic acid, L-ascorbic acid phosphate ester, and D-glucose; (b) potassium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, L-ascorbic acid, L-ascorbic acid phosphate ester, glycine, and D-glucose; (c) potassium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, L-ascorbic acid, L-ascorbic acid phosphate ester, L-cysteine, glycine, and D-glucose; or (d) potassium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, L-ascorbic acid, L-ascorbic acid phosphate ester, L-cysteine, glycine, an iron compound, and D-glucose.

Abstract: An image processing apparatus includes a display control unit configured to scroll a plurality of pieces of content data, a prediction unit configured to predict which content data among the plurality of pieces of content data moves from a hidden area to a display area according to a scroll display control condition controlled by the display control unit, and a decoding unit configured to decode the content data predicted by the prediction unit before the predicted content data moves to the display area.

Abstract: An image processing apparatus includes a display control unit configured to scroll a plurality of pieces of content data, a prediction unit configured to predict which content data among the plurality of pieces of content data moves from a hidden area to a display area according to a scroll display control condition controlled by the display control unit, and a decoding unit configured to decode the content data predicted by the prediction unit before the predicted content data moves to the display area.

Abstract: A projection apparatus among a plurality of projection apparatuses for executing multi-projection includes a holding unit configured to hold setting information about a role of the projection apparatus among the plurality of projection apparatuses for executing the multi-projection, a reception unit configured to receive an instruction for displaying a menu screen for changing a setting of the projection apparatus, a determination unit configured to determine whether to display the menu screen upon reception of the instruction by the reception unit, based on the setting information held by the holding unit, and a projection unit configured to project the menu screen according to a result of determination by the determination unit.

Abstract: An object of the present invention is to provide a regulatory dendritic cell inducing agent applicable to the treatment of immune disease as well as an immune tolerance inducing agent such as a preventive and/or therapeutic agent for allergic disease and a preventive and/or therapeutic agent for autoimmune disease, both of which are safe and have the mechanism of action different from that of conventional drugs. As a means for achieving the above object, an immune tolerance inducing agent comprising 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of the 5-ALA or the derivative and an iron compound as active ingredients is prepared. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.

Abstract: The present invention provides an agent for promoting graft survival which can suppress rejection without use of existing immunosuppressants, an organ preservation solution capable of maintaining the freshness of an organ excised from a donor, and the like. An agent for promoting graft survival or an organ preservation solution is prepared, which comprises 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of ALA or the derivative and an iron compound as active ingredients. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.

Abstract: The present invention provides an agent for promoting graft survival which can suppress rejection without use of existing immunosuppressants, an organ preservation solution capable of maintaining the freshness of an organ excised from a donor, and the like. An agent for promoting graft survival or an organ preservation solution is prepared, which comprises 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of ALA or the derivative and an iron compound as active ingredients. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.

Abstract: The present invention provides an agent for promoting graft survival which can suppress rejection without use of existing immunosuppressants, an organ preservation solution capable of maintaining the freshness of an organ excised from a donor, and the like. An agent for promoting graft survival or an organ preservation solution is prepared, which comprises 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of ALA or the derivative and an iron compound as active ingredients. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.

Abstract: An object of the present invention is to provide a preventive and/or therapeutic agent for radiation damage that has a novel mechanism of action and can prevent and alleviate a wide range of symptoms of radiation damage for which no therapeutic measures have been available so far, and moreover, is highly safe to humans. A preventive and/or therapeutic agent for radiation damage comprising a compound represented by the following formula (I) such as 5-aminolevulinic acid (5-ALA) or a salt thereof as an active ingredient can be used to improve the survival rate, improve body weight reduction, and alleviate hematopoietic disorder: (wherein R1 represents a hydrogen atom or an acyl group; and R2 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aryl group, or an aralkyl group).

Abstract: An object of the present invention is to provide a regulatory dendritic cell inducing agent applicable to the treatment of immune disease as well as an immune tolerance inducing agent such as a preventive and/or therapeutic agent for allergic disease and a preventive and/or therapeutic agent for autoimmune disease, both of which are safe and have the mechanism of action different from that of conventional drugs. As a means for achieving the above object, an immune tolerance inducing agent comprising 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of the 5-ALA or the derivative and an iron compound as active ingredients is prepared. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.

Abstract: The power consumption of a computer is dynamically managed independent of the OS or applications and without any delay time caused by system control. A blade server has server blades each including a processor, a power-saving control unit and a power sensor unit; a power supply box that supplies power to the server blades; and a single service processor which defines an electric current consumption upper limit value in the power sensor unit via the power-saving control unit of each server blade. When the electric current consumption of the server blades exceeds the electric current consumption upper limit value, a signal outputted by the power sensor unit is communicated to the processor, the operating frequency of the processor is controlled, and the maximum average power is controlled to be at or below the power consumption upper limit value.

Abstract: The present invention provides an agent for promoting graft survival which can suppress rejection without use of existing immunosuppressants, an organ preservation solution capable of maintaining the freshness of an organ excised from a donor, and the like. An agent for promoting graft survival or an organ preservation solution is prepared, which comprises 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of ALA or the derivative and an iron compound as active ingredients. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.

Abstract: An image processing apparatus includes a display control unit configured to scroll a plurality of pieces of content data, a prediction unit configured to predict which content data among the plurality of pieces of content data moves from a hidden area to a display area according to a scroll display control condition controlled by the display control unit, and a decoding unit configured to decode the content data predicted by the prediction unit before the predicted content data moves to the display area.

Abstract: An image processing apparatus includes a display control unit configured to scroll a plurality of pieces of content data, a prediction unit configured to predict which content data among the plurality of pieces of content data moves from a hidden area to a display area according to a scroll display control condition controlled by the display control unit, and a decoding unit configured to decode the content data predicted by the prediction unit before the predicted content data moves to the display area.

Abstract: The power consumption of a computer is dynamically managed independent of the OS or applications and without any delay time caused by system control. A blade server has server blades each including a processor, a power-saving control unit and a power sensor unit; a power supply box that supplies power to the server blades; and a single service processor which defines an electric current consumption upper limit value in the power sensor unit via the power-saving control unit of each server blade. When the electric current consumption of the server blades exceeds the electric current consumption upper limit value, a signal outputted by the power sensor unit is communicated to the processor, the operating frequency of the processor is controlled, and the maximum average power is controlled to be at or below the power consumption upper limit value.

Abstract: An image processing apparatus includes a display control unit configured to scroll a plurality of pieces of content data, a prediction unit configured to predict which content data among the plurality of pieces of content data moves from a hidden area to a display area according to a scroll display control condition controlled by the display control unit, and a decoding unit configured to decode the content data predicted by the prediction unit before the predicted content data moves to the display area.

Abstract: The present invention relates to a preventive and/or therapeutic agent for spinal canal stenosis comprising aldose reductase inhibitory compounds. A representative example of aldose reductase inhibitory compounds is the compound represented by formula (I): wherein all the symbols represent the same meaning as described in the specification; a salt of its acid when R3a represents hydrogen, or solvate thereof The therapeutic agent of the present invention is effective for prevention and/or therapy for spinal canal stenosis and the like, such as lumbar spinal canal stenosis.

Abstract: An object is to provide a sound generation method for basic information having chaos and fractal, so that a sound is generated by converting basic information having chaos and fractal into data that are numerically operable, by calculating characteristics of chaos and fractal from the basic information, which has chaos and fractal, and by applying a generation rule to the data of chaos and fractal.

Abstract: Reciprocating cutting tools (1, 90, 100) may include a drive source (11) for reciprocally driving a blade (B). The drive source may also drive a blower (13) in order to generate an air stream. An air channel (50, 56, 50, 70, 85, 80) may guide the air stream to a position adjacent to the blade or a workpiece (W) that will be cut by the blade. Further, a chip collector nozzle (57) may draw or suction cutting chips away from the workpiece that has been cut by the blade.

Abstract: Reciprocating cutting tools (1, 90, 100) may include a drive source (11) for reciprocally driving a blade (B). The drive source may also drive a blower (13) in order to generate an air stream. An air channel (50, 56, 50, 70, 85, 80) may guide the air stream to a position adjacent to the blade or a workpiece (W) that will be cut by the blade. Further, a chip collector nozzle (57) may draw or suction cutting chips away from the workpiece that has been cut by the blade.